Akorn Holding Company LLC is a Delaware-based holding company and reorganized successor to Akorn, Inc. (formerly NASDAQ: AKRX), operating through Akorn Operating Company LLC as a specialty generic pharmaceutical manufacturer. It develops, manufactures, and markets sterile injectable, ophthalmic, topical, and oral solution products sold to hospitals, retail pharmacies, and government agencies across the United States. Subsidiaries have included Akorn Animal Health, Hi-Tech Pharmacal, and Inspire Pharmaceuticals, with facilities in Illinois, New York, New Jersey, and Hettlingen, Switzerland.